As of 2025-07-05, the Fair Value of Australian Clinical Labs Ltd (ACL.AX) is 3.88 AUD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.81 AUD, the upside of Australian Clinical Labs Ltd is 38.01%.
With the market price of 2.81 AUD and our fair value calculation, Australian Clinical Labs Ltd (ACL.AX) is a good investment. Investing in ACL.AX stocks now will result in a potential gain of 38.01%.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 5Y Avg | |
| Net income | 41.26 | 60.37 | 178.24 | 35.90 | 23.93 | 67.94 |
| YoY growth | 492.01% | 46.34% | 195.24% | -79.86% | -33.33% | 124.08% |
| Market Cap (mil) | 555.57 |
| P/E | 18.11x |
| Forward P/E | 20.03x |
| EPS | 0.16 |
| Avg earnings growth rate | 124.08% |
| TTM earnings | 30.67 |